MUHC designated first provincial establishment for islet cell transplants for patients with type 1 diabetes

Non-invasive procedure allows patients to live without fear of severe hypoglycemia and even without insulin injections The McGill University Health Centre (MUHC) is...
July 7, 2022

RI-MUHC study highlights the role of fat metabolism enzyme in aggressive prostate cancer

A fatty acid metabolism enzyme drives prostate cancer aggressiveness and may help to predict poor clinical outcome A recent publication in Oncogene by...
July 6, 2022

The ultimate snapshot of ALS

The Neuro and its C-BIG Repository are at the heart of a Canadian initiative that invites individuals with ALS to share their unique...
June 28, 2022

Melanoma map shows skin cancer is on the rise in Canada

Higher rates of skin cancer affecting those living in southern and coastal areas of Canada Rates of melanoma, a deadly form of skin...
June 28, 2022

RI-MUHC trainee receives oral presentation prize from Canadian Conference on Ovarian Cancer Research

Doctoral student Wejdan Alenezi proposes new genes to predict ovarian cancer risk Wejdan Alenezi, a doctoral candidate in human genetics at McGill University...
June 28, 2022

Taking opioids at home after surgery: More harms than benefits

A new study conducted at the RI-MUHC concludes that prescribing opioid analgesics at discharge after surgery does not reduce postoperative pain and increases...
June 28, 2022

Giving teens with MS more treatment options

The first ever pediatric trial at The Neuro hopes to broaden the limited options for young people with Multiple Sclerosis We often think...
June 16, 2022

Climate Wise: Medical students lead development of evidence-based tool to integrate planetary health into medical curricula

Deemed the greatest threat to global health of the 21st century by the World Health Organization, climate change and its effects on human...
June 8, 2022

New study: Montreal researchers identify three drugs that could reduce mortality in severely ill COVID-19 patients

Researchers from the RI-MUHC and the McGill Genome Centre examine differences in ICU patients who recovered or died from COVID-19 and identify candidate...
June 8, 2022

New study reveals impact of COVID-19 pandemic on Quebec’s nurses

During the first wave of the COVID-19 pandemic, researcher and Professor Céline Gélinas believed it was important to survey Quebec nursing staff to...
June 8, 2022

McGill supports clinical innovation, one CLIC at a time

On May 10, the McGill community gathered virtually to celebrate innovation during the Fifth Annual McGill Clinical Innovation Competition (CLIC). Inspired by founding...
June 6, 2022

McGill team uncovers root causes of neuropathic pain

Discovery of underlying mechanism behind the debilitating and difficult to treat nerve condition could lead to new therapies Neuropathic pain is a common...
June 6, 2022

Shedding light on Parkinson’s toward new treatments and cures

An observational study led by The Michael J. Fox Foundation is looking for people recently diagnosed with Parkinson’s, and those with risk factors,...
June 6, 2022

4 Burning Questions for…. Steffanie Strathdee, AMR Symposium keynote speaker

On June 20, Steffanie Strathdee, PhD, will deliver the keynote address at the second Annual McGill Antimicrobial Resistance (AMR) Symposium, titled Superbugged: The...
June 3, 2022